The Scan

As GenomeWeb reports, the Food and Drug Administration has issued an Emergency Use Authorization for a CRISPR-based test for SARS-CoV-2.

In Science this week: mass spectrometric analysis of the SARS-CoV-2 spike protein, and more.

Researchers are wondering how the COVID-19 pandemic may affect results from clinical trials that continued and how to account for that influence, ScienceInsider reports.

In Nature this week: method to cluster cells based on single-cell RNA sequencing reads, synthetic genomics platform reconstructs SARS-CoV-2, and more.

The Washington Post reports former BARDA Director Rick Bright alleges in a whistleblower complaint he was removed from his post for trying to "prioritize science and safety over political expediency."

In Genome Research this week: target-mismatched sgRNA in microbial genome editing, strategy to examine gene expression throughout the cell cycle, and more.

In a preprint, University of Bonn researchers report a SARS-CoV-2 infection rate of 15.5 percent in Gangelt, Germany.

In PNAS this week: biomarker of activity of protein encoded by HTRA1 in age-related macular degeneration, evolutionary history of lions, and more.

The Guardian reports that the UK government has released the names of dozens of members of the Scientific Advisory Group for Emergencies.

In PLOS this week: gene alteration linked to glaucoma, genome sequencing traces origin of lager yeast, and more.

The US Centers for Disease Control and Prevention has launched a SARS-CoV-2 genome sequencing consortium, the New York Times reports.

In Science this week: a microRNA regulates extracellular vesicle secretion from prostate cancer cells, and more.